NAYA Key Statistics, Chart & Performance
The current stock price of NAYA is 2.2 USD. In the past month the price decreased by -7.56%.
NAYA Technical Analysis
NAYA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to NAYA. NAYA has a bad profitability rating. Also its financial health evaluation is rather negative.
NAYA Financial Highlights
Over the last trailing twelve months NAYA reported a non-GAAP Earnings per Share(EPS) of -2.96. The EPS increased by 76.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -43.87% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NAYA Forecast & Estimates
7 analysts have analysed NAYA and the average price target is 6.12 USD. This implies a price increase of 178.18% is expected in the next year compared to the current price of 2.2.
For the next year, analysts expect an EPS growth of -3770% and a revenue growth 125.23% for NAYA
NAYA Ownership
NAYA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.02 | 188.146B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.95 | 169.625B | ||
| SYK | STRYKER CORP | 23.97 | 137.924B | ||
| BSX | BOSTON SCIENTIFIC CORP | 22.17 | 111.924B | ||
| BDX | BECTON DICKINSON AND CO | 13.75 | 59.33B | ||
| IDXX | IDEXX LABORATORIES INC | 43.44 | 51.339B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.38 | 46.291B | ||
| RMD | RESMED INC | 21.75 | 38.394B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.39 | 37.64B | ||
| DXCM | DEXCOM INC | 27.76 | 27.621B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NAYA
Company Profile
INVO Fertility Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Sarasota, Florida and currently employs 25 full-time employees. The company went IPO on 2008-11-11. INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition, and operation of fertility clinics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution into third-party owned and operated fertility clinics. The INVOcell is a proprietary medical device that allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
Company Info
NAYA BIOSCIENCES INC
5582 Broadcast Court
Sarasota FLORIDA US
Employees: 25
Phone: 19788789505
NAYA BIOSCIENCES INC / NAYA FAQ
What does NAYA BIOSCIENCES INC do?
INVO Fertility Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Sarasota, Florida and currently employs 25 full-time employees. The company went IPO on 2008-11-11. INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition, and operation of fertility clinics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution into third-party owned and operated fertility clinics. The INVOcell is a proprietary medical device that allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
What is the current price of NAYA stock?
The current stock price of NAYA is 2.2 USD. The price increased by 8.37% in the last trading session.
Does NAYA BIOSCIENCES INC pay dividends?
NAYA does not pay a dividend.
What is the ChartMill technical and fundamental rating of NAYA stock?
NAYA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
On which exchange is NAYA stock listed?
NAYA stock is listed on the Nasdaq exchange.
What is the GICS sector and industry of NAYA stock?
NAYA BIOSCIENCES INC (NAYA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the next earnings date for NAYA stock?
NAYA BIOSCIENCES INC (NAYA) will report earnings on 2025-05-13.